InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Glessner Coleen, VP Exécutif. Insider active across 1 company, notably Emergent BioSolutions Inc.. Aggregated, 19 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €263k. History available since 8 April 2022. The latest transaction was filed on 29 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Glessner Coleen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
2,018 股Common StockSEC:0001919170-26-000016:0
100,111 股0Common StockSEC:0001919170-26-000012:0
8,199 股@ US$8.447.7% 占其流量Common StockSEC:0001919170-26-000009:0
313 股@ US$8.150.3% 占其流量Common StockSEC:0001919170-26-000006:0
28,847 股@ US$10.9234.8% 占其流量Common StockSEC:0001919170-26-000003:0
30,608 股@ US$10.000.064% mcap50.0% 占其流量Common StockSEC:0001919170-25-000004:0
1,249 股@ US$6.631.6% 占其流量Common StockSEC:0001367644-25-000143:0
480 股@ US$4.440.3% 占其流量Common StockSEC:0001367644-25-000092:0
62,500 股0Common StockSEC:0001367644-25-000047:0
5,913 股0Common StockSEC:0001367644-25-000034:0
18,674 股@ US$9.0122.8% 占其流量Common StockSEC:0001367644-24-000191:0
1,249 股@ US$6.191.0% 占其流量Common StockSEC:0001367644-24-000106:0
585 股@ US$2.290.2% 占其流量Common StockSEC:0001367644-24-000049:0
381 股@ US$3.390.2% 占其流量Common StockSEC:0001367644-24-000024:0
15,385 股0Common StockSEC:0001367644-23-000124:0
480 股0Common StockSEC:0001367644-23-000080:0
3,846 股0Common StockSEC:0001367644-23-000070:0
24,078 股0Common StockSEC:0001367644-22-000156:0
5,913 股0Common StockSEC:0001367644-22-000063:0
19 条申报中的 19 条
About Glessner Coleen
Coleen Glessner is the Executive Vice President of Quality and Ethics at Emergent BioSolutions Inc. She oversees the company's quality and ethics initiatives, ensuring compliance and integrity in operations. Her role is crucial for Emergent's reputation.
